Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    FDA 510(K) GUIDANCE, THE PROCEDURE TO PREPARE THE 2017 - How to Prepare a FDA 510(k) submission -By AtoZ Compliance

    View: 230

    Website https://www.atozcompliance.com/trainings-webinar/life-sciences/medical-devices/fda-510k-approval-pro | Want to Edit it Edit Freely

    Category Medical Device;Healthcare;Quality Control,Pharma,Biotech,medical device reporting training, sop medical device

    Deadline: April 25, 2017 | Date: April 25, 2017

    Venue/Country: Online, U.S.A

    Updated: 2017-02-14 19:38:10 (GMT+9)

    Call For Papers - CFP

    Key Take Away :

    This webinar will explain what the FDA 510(k) guidance is and the procedure to prepare the submission, the several types of 510(k), each part of the premarket notification – 510(k)submission including the very confusing concepts of predicate device and substantial equivalence.

    Overview :

    Understand FDA 510(k) process for medical devices. How to find an acceptable predicate device will be taught. FDA places special emphasis on device software. We will cover the FDA regulations for medical devices software.

    Why Should You Attend :

    Preparing a submission to get FDA approval for a new product is time consuming and confusing. The submission requirements refer to many unfamiliar concepts and terms such as predicate device and substantial equivalence. More than half of all submissions are rejected. We will teach you to prepare a submission meeting all the FDA requirements.

    Areas Covered In This Webinar :

    510(k) unique terminology

    Refuse to accept policy

    Learning Objectives :

    Learn how to submit a FDA 510(k) application

    What is a predicate device?

    Selecting a predicate device (substantial equivalence)

    Where to find substantially equivalent predicate devices

    How to handle software

    Who Will Benefit :

    Regulatory affairs (associates, specialists, managers, directors or VPs)

    Quality professionals (associates, specialists, managers, directors or VPs)

    R&D (engineers, scientists, managers, directors or VPs)

    Risk management personnel

    Operations Personnel (Medical/Pharma/Biotech)

    Quality/Regulatory/Compliance Consultants

    Validation/Verification/Documentation/Product/Process/Project (Mfg)

    Clinical affairs (associates, specialists, managers, directors or VPs)

    Engineering Personnel (Quality/Regulatory/Compliance)

    Software Developers (Medical/Pharma/Biotech)

    For more information, please visit : https://www.atozcompliance.com/trainings-webinar/life-sciences/medical-devices/fda-510k-approval-process-for-medical-devices/edwin-waldbusser/300207?utm_source=ref&utm_medium=25Apr

    Email: supportatatozcompliance.com

    Toll Free: +1- 844-414-1400

    Tel: +1-516-900-5509

    Level:

    Intermediate

    Speakers Profile :

    Edwin Waldbusser

    Edwin Waldbusser retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. Products included IVD devices, kidney dialysis systems and inhalation devices.

    His QS experience includes design control, risk analysis, CAPA, software validation, supplier qualification/control and manufacturing/non-conforming product programs.

    Ed has a B.S. Mechanical Engineering from NYU and a M.B.A from Drexel University. He is certified by Lloyds of London as an ISO 9000 Lead Auditor and is a member of the Thomson Reuters Expert Witness network. He has 5 issued patents.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.